206 related articles for article (PubMed ID: 21984218)
1. Comparative full-length sequence analysis of Marek's disease virus vaccine strain 814.
Zhang F; Liu CJ; Zhang YP; Li ZJ; Liu AL; Yan FH; Cong F; Cheng Y
Arch Virol; 2012 Jan; 157(1):177-83. PubMed ID: 21984218
[TBL] [Abstract][Full Text] [Related]
2. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
3. Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing.
Spatz SJ; Rue CA
Virus Genes; 2008 Jun; 36(3):479-89. PubMed ID: 18351449
[TBL] [Abstract][Full Text] [Related]
4. [Mutational analysis of Meq, RLORF4, RLORF12 and 132bpr genes of epidemic Marek's disease virus strains highly passaged on chicken embryo fibroblast].
Liu AL; Liu CJ; Zhang YP; Li JM; Shi WS; Yan FH; Zhang F; Cheng ZW
Bing Du Xue Bao; 2009 Sep; 25(5):368-75. PubMed ID: 19954114
[TBL] [Abstract][Full Text] [Related]
5. Comparative genomic sequence analysis of the Marek's disease vaccine strain SB-1.
Spatz SJ; Schat KA
Virus Genes; 2011 Jun; 42(3):331-8. PubMed ID: 21336949
[TBL] [Abstract][Full Text] [Related]
6. Sequence analysis of meq oncogene among Polish strains of Marek's disease.
Woźniakowski G; Samorek-Salamonowicz E; Kozdruń W
Pol J Vet Sci; 2010; 13(2):263-7. PubMed ID: 20731180
[TBL] [Abstract][Full Text] [Related]
7. Increased virulence of Marek's disease virus type 1 vaccine strain CV1988 after adaptation to qt35 cells.
Majerciak V; Valkova A; Szabová D; Geerligs H; Zelník V
Acta Virol; 2001 Apr; 45(2):101-8. PubMed ID: 11719980
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between pathogenic serotype 1 isolates of Marek's disease virus and the Rispens CVI988 vaccine in Australia using real-time PCR and high resolution melt curve analysis.
Renz KG; Cheetham BF; Walkden-Brown SW
J Virol Methods; 2013 Jan; 187(1):144-52. PubMed ID: 23041147
[TBL] [Abstract][Full Text] [Related]
9. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
Buscaglia C; Nervi P; Risso M
Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of Marek's disease virus (MDV) glycoprotein-, lytic antigen pp38- and transformation antigen Meq-encoding genes: association of meq mutations with MDVs of high virulence.
Shamblin CE; Greene N; Arumugaswami V; Dienglewicz RL; Parcells MS
Vet Microbiol; 2004 Sep; 102(3-4):147-67. PubMed ID: 15327791
[TBL] [Abstract][Full Text] [Related]
11. Insertion of reticuloendotheliosis virus long terminal repeat into the genome of CVI988 strain of Marek's disease virus results in enhanced growth and protection.
Lupiani B; Lee LF; Kreager KS; Witter RL; Reddy SM
Avian Dis; 2013 Jun; 57(2 Suppl):427-31. PubMed ID: 23901756
[TBL] [Abstract][Full Text] [Related]
12. Variations in the H/ACA box sequence of viral telomerase RNA of isolates of CVI988 Rispens vaccine.
Debba-Pavard M; Le Galludec H; Dambrine G; Rasschaert D
Arch Virol; 2008; 153(8):1563-8. PubMed ID: 18594940
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1.
Spatz SJ; Silva RF
Virus Genes; 2007 Aug; 35(1):41-53. PubMed ID: 16964553
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Marek's disease herpesvirus vaccine virus genome load in feather tips with protection, using an experimental challenge model.
Baigent SJ; Smith LP; Currie RJ; Nair VK
Avian Pathol; 2007 Dec; 36(6):467-74. PubMed ID: 17994325
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of vaccine efficacy of recombinant Marek's disease virus vaccine lacking Meq oncogene in commercial chickens.
Lee LF; Kreager KS; Arango J; Paraguassu A; Beckman B; Zhang H; Fadly A; Lupiani B; Reddy SM
Vaccine; 2010 Feb; 28(5):1294-9. PubMed ID: 19941987
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a very virulent Marek's disease virus mutant expressing the pp38 protein from the serotype 1 vaccine strain CVI988/Rispens.
Lee LF; Cui X; Cui Z; Gimeno I; Lupiani B; Reddy SM
Virus Genes; 2005 Aug; 31(1):73-80. PubMed ID: 15965611
[TBL] [Abstract][Full Text] [Related]
17. [Isolation and characterization of a non-pathogenic Marek's disease virus with a naturally inserted REV LTR sequence].
Chen R; Luo Q; Guo' K; Liu Z; Li H; Wang J
Wei Sheng Wu Xue Bao; 2014 Jun; 54(6):670-8. PubMed ID: 25272816
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of oncogenic genes revealed unique evolutionary features of field Marek's disease virus prevalent in recent years in China.
Tian M; Zhao Y; Lin Y; Zou N; Liu C; Liu P; Cao S; Wen X; Huang Y
Virol J; 2011 Mar; 8():121. PubMed ID: 21406076
[TBL] [Abstract][Full Text] [Related]
19. The detection of the meq gene in chicken infected with Marek's disease virus serotype 1.
Chang KS; Lee SI; Ohashi K; Ibrahim A; Onuma M
J Vet Med Sci; 2002 May; 64(5):413-7. PubMed ID: 12069073
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Gallid herpesvirus 2 with interrupted meq genes confers safe and efficacious protection against virulent field strains.
Zhang Y; Liu C; Yan F; Liu A; Cheng Y; Li Z; Sun G; Lv H; Wang X
Vaccine; 2017 Aug; 35(36):4695-4701. PubMed ID: 28754487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
